CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results (Q35953372)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
scientific article

    Statements

    CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results (English)
    Brian G Till
    Michael C Jensen
    Jinjuan Wang
    Xiaojun Qian
    Ajay K Gopal
    Catherine G Lindgren
    Yukang Lin
    John M Pagel
    Lihua E Budde
    Andrew Raubitschek
    Stephen J Forman
    Philip D Greenberg
    Stanley R Riddell
    Oliver W Press
    3 February 2012
    119
    3940-3950

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit